Avid Bioservices Inc (CDMO)
10.27
+0.31
(+3.11%)
USD |
NASDAQ |
Nov 01, 16:00
10.28
+0.01
(+0.10%)
After-Hours: 20:00
Avid Bioservices Debt to Equity Ratio: 2.624 for July 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2024 | 2.624 |
| April 30, 2024 | 2.522 |
| January 31, 2024 | 0.7849 |
| October 31, 2023 | 0.7685 |
| July 31, 2023 | 0.7392 |
| April 30, 2023 | 0.7434 |
| January 31, 2023 | 0.7571 |
| October 31, 2022 | 0.7732 |
| July 31, 2022 | 0.7812 |
| April 30, 2022 | 0.7997 |
| January 31, 2022 | 2.462 |
| October 31, 2021 | 2.721 |
| July 31, 2021 | 3.110 |
| April 30, 2021 | 1.247 |
| January 31, 2021 | 0.00 |
| October 31, 2020 | 0.00 |
| July 31, 2020 | 0.00 |
| April 30, 2020 | 0.1045 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 0.00 |
| April 30, 2014 | 0.00 |
| January 31, 2014 | 0.00 |
| October 31, 2013 | 0.00 |
| July 31, 2013 | 0.00 |
| April 30, 2013 | 0.00 |
| January 31, 2013 | 0.00 |
| October 31, 2012 | 0.00 |
| July 31, 2012 | 0.00 |
| April 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jan 2020
3.110
Maximum
Jul 2021
1.102
Average
0.7732
Median
Oct 2022
Debt to Equity Ratio Benchmarks
| MEI Pharma Inc | -- |
| Altimmune Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 334.64M |
| Total Liabilities (Quarterly) | 276.01M |
| Shareholders Equity (Quarterly) | 58.64M |
| Current Ratio | 1.458 |
| Net Debt Paydown Yield | -0.40% |